Hutchison China MediTech Ltd ADR Stock
The price for the Hutchison China MediTech Ltd ADR stock decreased slightly today. Compared to yesterday there is a change of -€0.100 (-0.880%).
Currently there is a rather positive sentiment for Hutchison China MediTech Ltd ADR with 3 Buy predictions and 1 Sell predictions.
As a result the target price of 17 € shows a very positive potential of 50.44% compared to the current price of 11.3 € for Hutchison China MediTech Ltd ADR.
Pros and Cons of Hutchison China MediTech Ltd ADR in the next few years
Pros
?
M***** P*******
?
B****
?
C******** o* t** e**********
Cons
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Hutchison China MediTech Ltd ADR vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Hutchison China MediTech Ltd ADR | -0.880% | -8.130% | -6.612% | -27.097% | 3.670% | -29.375% | -52.917% |
| China Traditional Chinese Medicine Co Ltd | -2.880% | -4.717% | -2.885% | -12.931% | -7.339% | -57.741% | -60.777% |
| China Resources Pharmaceutical Group Ltd | 0.420% | -2.033% | 2.553% | -24.094% | 1.261% | -36.993% | -13.153% |
| Repligen Corp. | -1.080% | -7.268% | -16.713% | -28.543% | -24.814% | -40.088% | -36.089% |
Comments
HUTCHMED (NASDAQ:HCM) was upgraded by analysts at Wall Street Zen from a "hold" rating to a "buy" rating.
Show more
Ratings data for HCM provided by MarketBeat
HUTCHMED (NASDAQ:HCM) was downgraded by analysts at Morgan Stanley from an "equal weight" rating to an "underweight" rating. They now have a $13.75 price target on the stock.
Show more
Ratings data for HCM provided by MarketBeat
HUTCHMED (China) Limited Sponsored ADR (NASDAQ: HCM) had its price target raised by analysts at Bank of America Corporation from $27.00 to $28.00. They now have a "buy" rating on the stock.
Show more
Ratings data for HCM provided by MarketBeat